Biotech Values

[mcbio]

INCY's Jakafi: FDA approves first drug to treat a rare bone marrow disease

Anyone surprised INCY only closed up a few percentage points after approval of their lead drug? Isn't this a sizeable market that the lead drug is going after and doesn't INCY have reasonable terms in their partnership? I may actually warm up a bit towards INCY now with the approval now in-hand, the stock not much higher, and still the promise of the RA drug, among others, to come. Curious to hear thoughts from others on INCY's valuation now after the approval.